Jude A. is a bioinformatician at the National Center for Tumor Diseases (NCT) Heidelberg since January 2021, focusing on data analysis for the MASTER precision oncology program. Previously, Jude served as a postdoctoral researcher at the DKFZ German Cancer Research Center, implementing spatial transcriptomics technologies for human bone marrow in myeloma studies. As a PhD candidate at HI-STEM/DKFZ from October 2016 to August 2020, Jude developed methods for analyzing bone marrow architecture with single-cell RNA sequencing and investigated hematopoietic stem cell heterogeneity. Prior experience includes work as a research associate at Indiana University, studying circadian dysregulation in diabetic retinopathy, and as a visiting researcher at the University of Florida, exploring molecular mechanisms behind diabetic retinopathy. Jude holds a PhD from DKFZ German Cancer Research Center and a Master’s degree in Molecular Biotechnology from Heidelberg University.